Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNYSE:HIMSNASDAQ:OPCHNASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$41.98-4.7%$43.76$18.01▼$52.92$5.20B1.492.21 million shs4.05 million shsHIMSHims & Hers Health$49.80+18.9%$32.39$11.64▼$72.98$11.06B1.8417.58 million shs156.79 million shsOPCHOption Care Health$32.74-0.2%$33.33$21.39▼$35.53$5.36B0.761.83 million shs1.78 million shsPGNYProgyny$23.36-0.2%$21.91$13.39▼$33.84$2.00B1.371.75 million shs1.04 million shs5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health-4.70%-15.24%+3.45%-11.81%+119.79%HIMSHims & Hers Health+18.75%+41.97%+92.07%+18.25%+327.49%OPCHOption Care Health-0.21%+6.68%-2.39%+4.53%+9.06%PGNYProgyny-0.17%+1.74%+3.36%+2.82%-27.90%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health4.4886 of 5 stars3.54.00.04.33.32.50.6HIMSHims & Hers Health2.3345 of 5 stars2.02.00.00.03.13.31.9OPCHOption Care Health3.0597 of 5 stars1.43.00.04.22.92.50.6PGNYProgyny1.0198 of 5 stars1.22.00.00.03.01.71.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.05Buy$52.3224.63% UpsideHIMSHims & Hers Health 2.08Hold$37.67-24.37% DownsideOPCHOption Care Health 2.88Moderate Buy$35.508.43% UpsidePGNYProgyny 2.38Hold$23.641.18% UpsideCurrent Analyst Ratings BreakdownLatest PGNY, HIMS, GH, and OPCH Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/6/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.005/6/2025HIMSHims & Hers HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$35.00 ➝ $39.005/6/2025HIMSHims & Hers HealthCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingSell ➝ Sell$25.00 ➝ $30.005/6/2025HIMSHims & Hers HealthNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$61.00 ➝ $61.005/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$52.00 ➝ $57.005/1/2025GHGuardant HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$60.00 ➝ $65.005/1/2025GHGuardant HealthTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$56.00 ➝ $60.005/1/2025GHGuardant HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$55.00 ➝ $60.005/1/2025GHGuardant HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$53.00 ➝ $60.005/1/2025GHGuardant HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $70.00(Data available from 5/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$774.00M6.72N/AN/A$1.34 per share31.33HIMSHims & Hers Health$1.48B7.49N/AN/A$1.61 per share30.93OPCHOption Care Health$5.19B1.03$1.90 per share17.19$8.03 per share4.08PGNYProgyny$1.17B1.71$0.66 per share35.58$5.77 per share4.05Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$479.45M-$3.39N/AN/AN/A-59.05%-19,157.20%-25.96%N/AHIMSHims & Hers Health-$23.55M$0.54113.1995.78N/A8.19%10.97%8.29%N/AOPCHOption Care Health$267.09M$1.2427.5125.982.304.37%15.30%6.57%N/APGNYProgyny$62.04M$0.5740.2835.942.395.03%11.36%7.87%5/8/2025 (Estimated)Latest PGNY, HIMS, GH, and OPCH EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PGNYProgyny$0.45N/AN/AN/A$307.86 millionN/A5/5/2025Q1 2025HIMSHims & Hers Health$0.12$0.20+$0.08$0.20$535.21 million$586.01 million4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion2/24/2025Q4 2024HIMSHims & Hers Health$0.09$0.11+$0.02$0.11$494.56 million$481.14 million2/20/2025Q4 2024GHGuardant Health-$0.75-$0.90-$0.15-$0.90$192.50 million$201.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AHIMSHims & Hers HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A6.225.85HIMSHims & Hers HealthN/A2.141.82OPCHOption Care Health0.771.731.32PGNYProgynyN/A2.622.62Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%HIMSHims & Hers Health63.52%OPCHOption Care Health98.05%PGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipGHGuardant Health5.50%HIMSHims & Hers Health17.71%OPCHOption Care Health0.64%PGNYProgyny9.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health1,790123.89 million116.76 millionNot OptionableHIMSHims & Hers Health650222.17 million179.79 millionOptionableOPCHOption Care Health5,600163.75 million169.09 millionOptionablePGNYProgyny31085.67 million74.68 millionOptionablePGNY, HIMS, GH, and OPCH HeadlinesRecent News About These CompaniesWhich Is a Better Investment, Progyny, Inc. or Surgery Partners, Inc. Stock?May 6 at 5:09 PM | aaii.comBastion Asset Management Inc. Acquires Shares of 50,044 Progyny, Inc. (NASDAQ:PGNY)May 6 at 6:49 AM | marketbeat.comState of Tennessee Department of Treasury Sells 45,198 Shares of Progyny, Inc. (NASDAQ:PGNY)May 5 at 4:05 AM | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Sold by Tower Research Capital LLC TRCMay 5 at 4:04 AM | marketbeat.comProgyny (PGNY) Projected to Post Earnings on ThursdayMay 3, 2025 | marketbeat.comProgyny (PGNY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseMay 1, 2025 | zacks.comPDT Partners LLC Takes $3.46 Million Position in Progyny, Inc. (NASDAQ:PGNY)May 1, 2025 | marketbeat.comNebula Research & Development LLC Has $721,000 Stake in Progyny, Inc. (NASDAQ:PGNY)May 1, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Sold by T. Rowe Price Investment Management Inc.April 28, 2025 | marketbeat.com13,318 Shares in Progyny, Inc. (NASDAQ:PGNY) Acquired by Cerity Partners LLCApril 27, 2025 | marketbeat.comMarshall Wace LLP Acquires Shares of 315,769 Progyny, Inc. (NASDAQ:PGNY)April 26, 2025 | marketbeat.com14,085 Shares in Progyny, Inc. (NASDAQ:PGNY) Purchased by Quantessence Capital LLCApril 25, 2025 | marketbeat.comLegal & General Group Plc Reduces Position in Progyny, Inc. (NASDAQ:PGNY)April 25, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Shares Sold by Envestnet Asset Management Inc.April 25, 2025 | marketbeat.comProgyny, Inc. Announces Details for Its First Quarter 2025 Results ReportApril 24, 2025 | globenewswire.comCanada Pension Plan Investment Board Takes Position in Progyny, Inc. (NASDAQ:PGNY)April 24, 2025 | marketbeat.comRussell Investments Group Ltd. Reduces Holdings in Progyny, Inc. (NASDAQ:PGNY)April 23, 2025 | marketbeat.comJump Financial LLC Sells 156,168 Shares of Progyny, Inc. (NASDAQ:PGNY)April 22, 2025 | marketbeat.comBarclays PLC Has $23.84 Million Stock Position in Progyny, Inc. (NASDAQ:PGNY)April 22, 2025 | marketbeat.comWhy Progyny (PGNY) is Poised to Beat Earnings Estimates AgainApril 21, 2025 | zacks.comFederated Hermes Inc. Sells 48,152 Shares of Progyny, Inc. (NASDAQ:PGNY)April 21, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?5 Highest-Rated Dividend Stocks According to MarketBeatBy Thomas Hughes | April 10, 2025View 5 Highest-Rated Dividend Stocks According to MarketBeatJoby Aviation Shares Eye Breakout After Transition Flight WinBy Jeffrey Neal Johnson | April 30, 2025View Joby Aviation Shares Eye Breakout After Transition Flight WinTesla Stock Eyes Breakout With Earnings on DeckBy Sam Quirke | April 16, 2025View Tesla Stock Eyes Breakout With Earnings on DeckAST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockBy Jea Yu | April 21, 2025View AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer StockPGNY, HIMS, GH, and OPCH Company DescriptionsGuardant Health NASDAQ:GH$41.98 -2.07 (-4.70%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$42.60 +0.62 (+1.48%) As of 05/6/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Hims & Hers Health NYSE:HIMS$49.80 +7.92 (+18.92%) Closing price 05/6/2025 03:59 PM EasternExtended Trading$49.80 0.00 (0.00%) As of 05/6/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.Option Care Health NASDAQ:OPCH$32.74 -0.07 (-0.21%) Closing price 05/6/2025 04:00 PM EasternExtended Trading$32.74 -0.01 (-0.02%) As of 05/6/2025 05:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.Progyny NASDAQ:PGNY$23.36 -0.04 (-0.17%) Closing price 05/6/2025 04:00 PM EasternExtended Trading$23.36 0.00 (0.00%) As of 05/6/2025 05:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Top-Ranked Insider Buys From April by Market Cap Palantir Stock Drops Despite Stellar Earnings: What's Next? Hims & Hers Stock Rises on Fundamentals and Squeeze Potential Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership? D-Wave Quantum: Hidden Opportunity or Short Seller's Dream? Microsoft Stock After Xbox Price Hike: Buy or Hold? Uncertainty Creates Opportunity for Tyson Foods Investors Why Wells Fargo Is Buying $40 Billion of Its Own Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
